PRL-3 as a Marker for Colorectal Cancer Aggressiveness
Author Information
Author(s): Molleví D G, Aytes A, Padullés L, Martínez-Iniesta M, Baixeras N, Salazar R, Ramos E, Figueras J, Capella G, Villanueva A
Primary Institution: Institut Català d’Oncologia-IDIBELL
Hypothesis
Can PRL-3 expression levels predict the recurrence of stage IIIB-C colorectal carcinoma?
Conclusion
PRL-3 is a good marker of aggressiveness in locally advanced colorectal cancer and a promising predictor of distant metastases.
Supporting Evidence
- PRL-3 overexpression was found in primary tumors compared to normal mucosa.
- High levels of PRL-3 were an independent predictor of metastasis.
- PRL-3 expression correlated with poor outcomes in colorectal cancer patients.
Takeaway
PRL-3 is a protein that helps doctors understand how aggressive a colorectal cancer is and if it might spread to other parts of the body.
Methodology
The study involved analyzing PRL-3 expression in primary colorectal tumors and liver metastases using xenografts and matched samples.
Limitations
The need to validate the cutoff value of PRL-3 expression in larger and consecutive series.
Participant Demographics
Patients with stage IIIB-C colorectal carcinoma.
Statistical Information
P-Value
P<0.0001
Confidence Interval
1.405–7.852
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website